StockNews.com Begins Coverage on Lexicon Pharmaceuticals (NASDAQ:LXRX)
StockNews.com began coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) in a research report sent to investors on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. Other equities research analysts also recently issued research reports about the company. HC Wainwright reissued a “buy” rating and issued a $4.00 price […]
More Stories
US Inflation Slows to Lowest Level Since February 2021
By Andrew Moran The U.S. annual inflation rate eased to its lowest level in more than four years, even as...
Jane Street Group LLC Grows Stake in Gerdau S.A. (NYSE:GGB)
Jane Street Group LLC increased its holdings in Gerdau S.A. (NYSE:GGB – Free Report) by 221.1% during the fourth quarter,...
Amazon.com, Inc. (NASDAQ:AMZN) Position Decreased by First Commonwealth Financial Corp PA
First Commonwealth Financial Corp PA lessened its holdings in Amazon.com, Inc. (NASDAQ:AMZN) by 1.0% during the fourth quarter, Holdings Channel.com...
Regal Investment Advisors LLC Sells 8,509 Shares of Amazon.com, Inc. (NASDAQ:AMZN)
Regal Investment Advisors LLC lowered its position in Amazon.com, Inc. (NASDAQ:AMZN) by 16.2% in the 4th quarter, HoldingsChannel.com reports. The...
Finer Wealth Management Inc. Has $9.72 Million Stake in Amazon.com, Inc. (NASDAQ:AMZN)
Finer Wealth Management Inc. boosted its holdings in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 1.4% in the 4th quarter, according...
Avenir Corp Decreases Stock Position in Amazon.com, Inc. (NASDAQ:AMZN)
Avenir Corp decreased its stake in Amazon.com, Inc. (NASDAQ:AMZN) by 3.4% during the fourth quarter, Holdings Channel.com reports. The institutional...